Jun 01, 2021 / 03:40PM GMT
John Charles Kreger - William Blair & Company L.L.C., Research Division - Partner & Co-Group Head of Healthcare Technology and Services
Good morning, everyone. Welcome back to the William Blair Growth Stock Conference. I'm John Kreger. And our next session is Certara. I'm the analyst that covers Certara. And before we get started, I've been instructed to let you know if you need to see any disclosures or conflicts, please see williamblair.com.
Here from the company is Bill Feehery, CEO; and Andy Schemick, CFO. We've got a half an hour of fireside chat format with Bill and Andy, so we're going to get going now. Any of you that are listening, if you do have questions, feel free to submit them to me and I'll do my best to get them into the discussion.
So Bill, thanks again for joining us. I know this is the first time you've been here at our conference, and Certara is a relatively new public company. Can you spend a few minutes just sort of setting the stage talking about Certara and what you view as the core value proposition?
Certara Inc at William Blair Growth Stock Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
